Alumni raised $1.45B in 2022 - Download Free Report Now

TESARO

Compounds for oncology indications, including: 1-the prevention of A) chemotherapy-induced nausea and vomiting (CINV), B) post-operative nausea and v....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of TESARO plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About TESARO

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With